1. Home
  2. JCE vs PROF Comparison

JCE vs PROF Comparison

Compare JCE & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCE
  • PROF
  • Stock Information
  • Founded
  • JCE 2007
  • PROF N/A
  • Country
  • JCE United States
  • PROF Canada
  • Employees
  • JCE N/A
  • PROF N/A
  • Industry
  • JCE Trusts Except Educational Religious and Charitable
  • PROF Medical/Dental Instruments
  • Sector
  • JCE Finance
  • PROF Health Care
  • Exchange
  • JCE Nasdaq
  • PROF Nasdaq
  • Market Cap
  • JCE 244.6M
  • PROF 238.5M
  • IPO Year
  • JCE N/A
  • PROF N/A
  • Fundamental
  • Price
  • JCE $15.38
  • PROF $7.71
  • Analyst Decision
  • JCE
  • PROF Strong Buy
  • Analyst Count
  • JCE 0
  • PROF 2
  • Target Price
  • JCE N/A
  • PROF $11.40
  • AVG Volume (30 Days)
  • JCE 49.7K
  • PROF 66.3K
  • Earning Date
  • JCE 01-01-0001
  • PROF 10-31-2024
  • Dividend Yield
  • JCE 9.26%
  • PROF N/A
  • EPS Growth
  • JCE N/A
  • PROF N/A
  • EPS
  • JCE N/A
  • PROF N/A
  • Revenue
  • JCE N/A
  • PROF $7,880,000.00
  • Revenue This Year
  • JCE N/A
  • PROF $56.87
  • Revenue Next Year
  • JCE N/A
  • PROF $161.94
  • P/E Ratio
  • JCE N/A
  • PROF N/A
  • Revenue Growth
  • JCE N/A
  • PROF 16.67
  • 52 Week Low
  • JCE $11.64
  • PROF $7.11
  • 52 Week High
  • JCE $14.28
  • PROF $11.69
  • Technical
  • Relative Strength Index (RSI)
  • JCE 58.50
  • PROF 41.09
  • Support Level
  • JCE $15.04
  • PROF $7.45
  • Resistance Level
  • JCE $15.39
  • PROF $7.77
  • Average True Range (ATR)
  • JCE 0.16
  • PROF 0.27
  • MACD
  • JCE 0.01
  • PROF 0.03
  • Stochastic Oscillator
  • JCE 78.32
  • PROF 14.69

About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest

Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities (the Options Strategy).

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: